Navigation

Investiment.io
Financial analysis platform

Eli Lilly and Company

LLY โ€ข NYSE

$1,431.67
โ–ผ11.83 (0.82%)โ€ข REGULAR

Eli Lilly and Company

$1,431.67
โ–ผ0.8%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading

๐Ÿ“ˆ Advanced DCF Valuation

Professional-grade discounted cash flow analysis with scenario modeling for LLY

Healthcare โ€ข Drug Manufacturers - General โ€ข Market Cap: $1,346,836,438,531.77

Scenario Analysis

Compare different scenarios to understand valuation sensitivity

๐Ÿ”ป-98.7% upside

Conservative Case

$18.80

๐Ÿ“Š-97.5% upside

Base Case

$36.43

๐Ÿ”บ-96.2% upside

Optimistic Case

$54.58

๐Ÿ’ฐMarket Price

Current Price

$1431.67

DCF Model & Results

Detailed cash flow projections and valuation analysis

๐Ÿ’ต Enhanced Cash Flow Projections

YearRevenueGrowth %Operating Margin %NOPATCapExFCFPV of FCF
1$80,992,906,249.8124.3%15.0%$9,597,659,390.60$1,816,365,316.93$10,132,011,729.91$9,215,244,312.90
2$97,191,487,499.7720.0%11.3%$8,637,893,451.54$2,031,302,088.75$9,441,343,081.54$7,810,091,445.19
3$111,770,210,624.7315.0%8.4%$7,450,183,101.95$2,168,761,224.41$8,561,634,580.66$6,441,547,253.05
4$125,182,635,899.7012.0%6.3%$6,258,153,805.64$2,275,363,404.04$7,671,207,352.22$5,249,384,696.43
5$137,700,899,489.6710.0%4.7%$5,162,976,889.65$2,355,323,108.56$6,876,089,447.83$4,279,542,722.56
Terminalโ€”3.0%โ€”โ€”โ€”$56,121,679,759.11$34,929,028,776.19
Enterprise Value$67,924,839,206.32
Net Debt$35,235,000,000.00
Equity Value$32,689,839,206.32
Price per Share$36.43
EV/Revenue (Final Year)0.5x
Terminal Value %51.4%
WACC9.9%

๐Ÿฅ Company Financial Health

Historical Revenue Growth24.3%
Current Operating Margin0.0%
FCF Conversion Rate25.8%
Net Debt/Equity0.00
ROE0.0%
ROIC0.0%
Beta1.20
Interest Coverage0.00
Enhanced DCF data sourced from Financial Modeling Prep (FMP) โ€ข Model incorporates industry best practices and academic research โ€ข Calculations are estimates and should not be used as sole investment advice โ€ข Consult with a financial advisor before making investment decisions